November 6, 2019 Liq. Handling & Robotics Microscopy PAI Top-10 PR/Corporate

Brooks Automation Reports Fourth Quarter and Year-End Results of Fiscal Year 2019, Ended September 30, 2019, and Announces Quarterly Cash Dividend

Brooks Automation Reports Fourth Quarter and Year-End Results of Fiscal Year 2019, Ended September 30, 2019, and Announces Quarterly Cash Dividend Revenue Growth at 24% Caps Off a Transformative Year of High Growth and Margin Expansion CHELMSFORD, Mass., Nov. 6, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS), a leader in automation solutions for the semiconductor... Read more

November 6, 2019 Acad, Gov/Utilities Licensing, IP, and Legal PAI Top-10 Product Launch

Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting

Basel, 06 November 2019 Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting Ten Roche medicines will be featured in more than 70 abstracts and 21 oral presentations, across a range of 15 blood cancers and non-malignant haematological conditions New data for CD20-CD3... Read more

November 6, 2019 Environ, Ag./Food & Bev PAI Top-10 Product Launch

Nalgene Outdoor Launches New Bottle Customization Feature

“Customizer” Shop Offers One-of-a-Kind Bottles; Creates Unique Water Bottles That Reflect Personal Styles ROCHESTER, N.Y., Nov. 6, 2019 /PRNewswire/ — Nalgene Outdoor, maker of reusable water bottles, launches its new “Customizer” online store , which offers Nalgene bottle fans a way to create individualized products quickly and easily– the perfect companion for everyday adventures! Nalgene Outdoor’s... Read more

November 6, 2019 Bio/Pharma/CRO Lab Top-10 PAI Top-10

GE Healthcare Life Sciences and Akeso Pharmaceuticals to speed up novel therapy manufacturing in China

GE Healthcare Life Sciences will supply Akeso Pharmaceuticals with the FlexFactory™ platform to accelerate the production of antibody drugs in the Guangzhou region Expected to be operational by end of 2020 and create up to 150 jobs upon opening. November 6, 2019 – Uppsala, Sweden and Guangzhou, China – Akeso Pharmaceuticals, a biotech company specializing... Read more

November 5, 2019 Clinical Research/Diagn. PAI Top-10

QIAGEN expands portfolio of immuno-oncology assets for future companion diagnostics and biomarkers

Collaborates with Repertoire Genesis for access to T-cell /B-cell receptor repertoire assays for clinical next-generation sequencing Acquires licensing rights for epigenomic (DNA methylation) immune checkpoint inhibitor biomarkers developed by researchers from the University of Bonn Receives exclusive license to novel mRNA gene expression signatures from STRATIFYER Molecular Pathology GmbH which may guide treatment decisions for... Read more

November 5, 2019 PAI Top-10

BD Announces Results For 2019 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2020 Guidance

FRANKLIN LAKES, N.J., Nov. 5, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.584 billion for the fourth fiscal quarter ended September 30, 2019.  This represents an increase of 4.1 percent over the prior-year period.  On a comparable, currency-neutral basis, revenues increased 6.2 percent... Read more

November 4, 2019 Acad, Gov/Utilities Lab Top-10 PAI Top-10 PR/Corporate

Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA

AUSTIN, Texas, Nov. 4, 2019 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2019. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”).  Comparisons shown in this release are to the same period in the prior year unless otherwise noted. CURRENT... Read more

October 31, 2019 Lab Top-10 PAI Top-10 PR/Corporate

Bruker Reports Third Quarter 2019 Financial Results

– Q3-19 revenue growth of 11.7% and organic revenue growth of 7.6% year-over-year BILLERICA, Mass., Oct. 31, 2019 /PRNewswire/ — Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2019. Third Quarter 2019 Financial Results Bruker’s revenues for the third quarter of 2019 were $521.1... Read more

October 30, 2019 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

PerkinElmer Announces Financial Results for the Third Quarter of 2019

Revenue of $706.9 million; 5% Reported growth; Organic growth of 5% GAAP EPS from continuing operations of $0.53; Adjusted EPS of $1.06 GAAP operating income margin from continuing operations of 11.1%; Adjusted operating income margin from continuing operations of 21.6% Acquisition of Meizheng Group, a food safety testing provider; bolsters assay capabilities in China Adjusting... Read more